Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients

Published:2007-04-24 Issue:10 Volume:96 Page:1504-1513
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

de Azambuja E,Cardoso F,de Castro G,Colozza M,Mano M S,Durbecq V,Sotiriou C,Larsimont D,Piccart-Gebhart M J,Paesmans M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6603756.pdf

Reference97 articles.

1. Alonzo TA (2005) Standards for reporting prognostic tumor marker studies. J Clin Oncol 23: 9053–9054

2. Beck T, Weller EE, Weikel W, Brumm C, Wilkens C, Knapstein PG (1995) Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognosis parameters and with the proliferation marker, MIB-1. Gynecol Oncol 57: 96–104

3. Bevilacqua P, Verderio P, Barbareschi M, Bonoldi E, Boracchi P, Dalla Palma P, Gasparini G (1996) Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma. Breast Cancer Res Treat 37: 123–133

4. Biesterfeld S, Kluppel D, Koch R, Schneider S, Steinhagen G, Mihalcea AM, Schroder W (1998) Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR. J Pathol 185: 25–31

5. Billgren AM, Tani E, Liedberg A, Skoog L, Rutqvist LE (2002) Prognostic significance of tumor cell proliferation analyzed in fine needle aspirates from primary breast cancer. Breast Cancer Res Treat 71: 161–170

Cited by 751 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer;Annals of Surgical Oncology;2024-09-09

2. In-Depth Analysis of the Peripheral Immune Profile of HER2+ Breast Cancer Patients on Neoadjuvant Treatment with Chemotherapy Plus Trastuzumab Plus Pertuzumab;International Journal of Molecular Sciences;2024-08-27

3. Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysis;Clinical and Translational Oncology;2024-08-18

4. Brain metastasis risk prediction model in females with hormone receptor-positive breast cancer;Radiotherapy and Oncology;2024-08

5. Breast Cancer: Extracellular Matrix and Microbiome Interactions;International Journal of Molecular Sciences;2024-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3